Vise Technologies Inc. Has $2.57 Million Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Vise Technologies Inc. grew its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 84.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,925 shares of the medical equipment provider's stock after buying an additional 2,256 shares during the quarter. Vise Technologies Inc.'s holdings in Intuitive Surgical were worth $2,571,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Atala Financial Inc purchased a new stake in Intuitive Surgical during the 4th quarter worth $25,000. Hurley Capital LLC purchased a new stake in Intuitive Surgical during the 4th quarter worth approximately $28,000. Berbice Capital Management LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at approximately $26,000. Parvin Asset Management LLC acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth approximately $26,000. Finally, BankPlus Trust Department acquired a new stake in Intuitive Surgical in the fourth quarter valued at $28,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the stock. Citigroup reissued a "buy" rating and issued a $650.00 target price (up previously from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Barclays reduced their target price on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a report on Thursday, April 24th. Robert W. Baird dropped their price target on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Evercore ISI lowered their target price on shares of Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a research note on Wednesday, April 23rd. Finally, CICC Research initiated coverage on shares of Intuitive Surgical in a research report on Monday, January 27th. They issued a "neutral" rating and a $550.00 price target on the stock. Five investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $596.05.

Intuitive Surgical Trading Up 1.9%

ISRG stock traded up $10.11 on Tuesday, hitting $549.65. 894,314 shares of the company's stock traded hands, compared to its average volume of 1,645,193. The stock has a market cap of $197.00 billion, a price-to-earnings ratio of 85.75, a P/E/G ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 1-year low of $396.15 and a 1-year high of $616.00. The stock has a fifty day moving average of $512.50 and a 200-day moving average of $538.12.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The business had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. During the same period last year, the company posted $1.50 EPS. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Brian Edward Miller sold 8,900 shares of the business's stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the sale, the executive vice president now directly owns 5,758 shares of the company's stock, valued at $2,793,033.06. The trade was a 60.72% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Myriam Curet sold 2,401 shares of the company's stock in a transaction on Thursday, February 27th. The shares were sold at an average price of $581.00, for a total value of $1,394,981.00. Following the transaction, the executive vice president now directly owns 353 shares in the company, valued at $205,093. The trade was a 87.18% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 32,700 shares of company stock worth $16,865,621 over the last ninety days. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.